Latest filing published 09 Mar 2026 for Henry Schein INC.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Filings by Reed Vaughn Tuckson span 3 companies, the busiest being Henry Schein Inc, CTI Biopharma Corp and Legacy Lifepoint Health, Inc. In total, 15 filings cover trades dated from 29 April 2016 to 6 March 2026.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 9 March 2026 came the latest disclosure, a share grant in Henry Schein Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations